CXCL10 gene therapy is a promising approach for the treatment of solid tumors such as ‎melanoma, ‎‎breast cancer, and lung cancer, where immune cell infiltration plays a crucial role ‎in disease control.79,80 Modern techniques such as CRISPR gene editing provide a precise ‎method to modulate gene ‎‎expression81 and can be developed to control the expression of ‎ CXCL10 in cancer cells, enabling ‎‎tailored therapeutic interventions. The gene discussed is CXCL10; the disease is breast carcinoma.